Clinical and Laboratory Standards Institute's scientific contributions
What is this page?
This page lists the scientific contributions of an author, who either does not have a ResearchGate profile, or has not yet added these contributions to their profile.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
It was automatically created by ResearchGate to create a record of this author's body of work. We create such pages to advance our goal of creating and maintaining the most comprehensive scientific repository possible. In doing so, we process publicly available (personal) data relating to the author as a member of the scientific community.
If you're a ResearchGate member, you can follow this page to keep up with this author's work.
If you are this author, and you don't want us to display this page anymore, please let us know.
Citations
... Antimicrobial susceptibility testing, including determination of minimum inhibitory concentration (MIC) breakpoints for meropenem, imipenem, colistin, tigecycline, and ceftazidime was performed using the broth microdilution method with the VITEK®2 system (bioMérieux, Marcy-l'Étoile, France). Interpretation of antimicrobial susceptibilities followed the guidelines established by the Clinical and Laboratory Standard Institute (CLSI) in 2020 [13]. Specifically, the MIC breakpoints for tigecycline and colistin/PMB were in accordance with the criteria provided by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) in 2020 [14]. ...
